Back to Agendas
Session 3: Learnings from Patient Engagement in Clinical Trials and Other Types of Health Research
Session Chair(s)
John F. P. Bridges, PhD
Professor, Departments of Biomedical Informatics
Ohio State University College of Medicine, United States
K. Kimberly McCleary
Founder and Chief Executive Officer
The Kith Collective, LLC, United States
Awareness of the importance of patient engagement in benefit-risk assessment and decision-making is growing, but there is still limited evidence about effective engagement practices. This session focuses on patient engagement in other aspects of the clinical trial, such as the qualification of patient-reported outcome measures (PROs), and in other types of health research, such as PCORI-funded research, and what can be learned from those experiences.
Speaker(s)
Panel Discussion
Darius Tandon, PhD
Northwestern University, United States
Ari Gnanasakthy, MBA, MS, MSc
Novartis Pharmaceuticals Corporation, United States
Head, Patient Reported Outcomes
Susan DosReis, PhD
University of Maryland School of Pharmacy, United States
Associate Professor, Dept. of Pharmaceutical Health Services Research
Panel Q&A
United States
Have an account?